PHARMACOKINETIC AND PHARMACODYNAMIC MODELING OF L-DOPA PLASMA-CONCENTRATIONS AND CLINICAL EFFECTS IN PARKINSONS-DISEASE AFTER SINEMET

被引：30

作者：

NELSON, MV

BERCHOU, RC

LEWITT, PA

KARETI, D

KESAREE, N

SCHLICK, P

GALLOWAY, MP

机构：

[1] WAYNE STATE UNIV,SCH MED,DETROIT,MI 48202

[2] HARPER HOSP,DEPT PHARM,DETROIT,MI 48201

[3] LAFAYETTE CLIN,DETROIT,MI 48207

来源：

CLINICAL NEUROPHARMACOLOGY | 1989年 / 12卷 / 02期

关键词：

D O I：

10.1097/00002826-198904000-00002

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：91 / 97

页数：7

共 15 条

[1]

Akaike H., 1976, MATH SCI, V14, P5

[2] CLINICAL PHARMACOKINETICS OF ANTI-PARKINSONIAN DRUGS [J].

CEDARBAUM, JM .

CLINICAL PHARMACOKINETICS, 1987, 13 (03) :141-178

[3] LEVODOPA PHARMACOKINETIC MECHANISMS AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE [J].

FABBRINI, G ;

JUNCOS, J ;

MOURADIAN, MM ;

SERRATI, C ;

CHASE, TN .

ANNALS OF NEUROLOGY, 1987, 21 (04) :370-376

[4] SIMULTANEOUS MODELING OF PHARMACOKINETICS AND PHARMACODYNAMICS WITH A NONPARAMETRIC PHARMACODYNAMIC MODEL [J].

FUSEAU, E ;

SHEINER, LB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) :733-741

[5]

GALLOWAY MP, 1986, J PHARMACOL EXP THER, V236, P689

[6]

HOLFORD NHG, 1981, CRC CR REV BIOM ENG, V5, P273

[7] UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS [J].

HOLFORD, NHG ;

SHEINER, LB .

CLINICAL PHARMACOKINETICS, 1981, 6 (06) :429-453

[8] DIETARY THERAPY FOR MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE [J].

KURLAN, R .

ARCHIVES OF NEUROLOGY, 1987, 44 (11) :1119-1121

[9] LEVODOPA PHARMACOKINETICS AND PHARMACODYNAMICS IN FLUCTUATING PARKINSONIAN-PATIENTS [J].

NUTT, JG ;

WOODWARD, WR .

NEUROLOGY, 1986, 36 (06) :739-744

[10]

NUTT JG, 1984, CLIN NEUROPHARMACOL, V7, P35

← 1 2 →